Liao, Yulin <br/><br/>
Celiprolol, a vasodilatory beta-blocker, inhibits pressure overload-induced cardiac hypertrophy and prevents the transition to heart failure via nitric oxide-dependent mechanisms in mice.  [electronic resource] 

 -  Circulation  Aug 2004 
 - 692-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1524-4539 
<br/><br/><label>Standard No.: </label>10.1161/01.CIR.0000137831.08683.E1  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adrenergic beta-1 Receptor Antagonists<br/>Adrenergic beta-Antagonists--pharmacology<br/>Animals<br/>Cardiomegaly--etiology<br/>Celiprolol--pharmacology<br/>Cells, Cultured--drug effects<br/>Disease Progression<br/>Drug Evaluation, Preclinical<br/>Enzyme Induction--drug effects<br/>Fibrosis<br/>Gene Expression Regulation--drug effects<br/>Heart Failure--etiology<br/>Hypertrophy<br/>Isoproterenol--pharmacology<br/>Male<br/>Mice<br/>Mice, Inbred C57BL<br/>Myocardium--pathology<br/>Myocytes, Cardiac--drug effects<br/>NG-Nitroarginine Methyl Ester--pharmacology<br/>Natriuretic Peptide, Brain--biosynthesis<br/>Nitric Oxide--physiology<br/>Nitric Oxide Synthase--genetics<br/>Nitric Oxide Synthase Type II<br/>Nitric Oxide Synthase Type III<br/>Phenylephrine--pharmacology<br/>Pressure--adverse effects<br/>RNA, Messenger--biosynthesis<br/>Rats<br/>Transcription, Genetic--drug effects<br/>Vasodilator Agents--pharmacology